The 37th Day in Primary Eye Care for Family Physicians

Transcription

The 37th Day in Primary Eye Care for Family Physicians
The 37th Day in Primary Eye Care for Family Physicians
Saturday, December 13, 2014
0700 - 0745 Registration and Continental Breakfast
0745 - 0800 Welcome - Dr. L. Weisbrod (Chairman)
Session 1
Moderator – Dr. Lawrence Weisbrod
0800 - 0830 Basic Anatomy, Physiology and Examination of the Eye
Dr. John Lloyd
0830 - 0845 TBD
0845 - 0900 An Approach to Diplopia
Dr. Arun Sundaram
0900 - 0915 Pediatric Emergencies in the First 6 Months of Life
Dr. Robert Adam
0915 - 0930 An Update on Amblyopia and Strabismus
Dr. Michael Richards
0930 - 0945 An Update on Glaucoma – Diagnostics
Dr. Catherine Birt
0945 - 1000 Question & Answer Period (Panel)
1000 - 1015 Refreshments & Exhibits
Session 2
Moderator - TBD
1015 – 1030 An Update on Glaucoma – Therapeutics
Dr. Catherine Birt
1030 - 1045 An Update on Age-Related Macular Degeneration
Dr. Daniel Weisbrod
1045 – 1100 Floaters and Flashes: What the Family Physician Needs to
Know
Dr. Efrem Mandelcorn
1100 - 1115 Traumatic Eye Disease – Part 1
Dr. Kylen McRealis
1115 - 1130 Traumatic Eye Disease – Part 2
Dr. Kylen McRealis
1130 - 1145 Mystery Slide Quiz - Part 1
Dr. John Fowler
1145 - 1200 Question & Answer Period (Panel)
1200 - 1300 Luncheon
Session 3
Moderator – Dr. John Fowler
1300 - 1315 Mystery Slide Quiz - Part 2
Dr. John Fowler
1315 – 1330 New Advances in Cataract Surgery
Dr. Moss Weinstock
1330 – 1345 Corneal Manifestations of Systemic Disease
Dr. Hall Chew
1345 - 1400 Involutional Changes to the Eyes and Face
Dr. Harmeet Gill
1400 - 1415 An Update on Refractive Eye Surgery
TBD
1415 – 1430 Question & Answer Period (Panel)
1430 - 1445 Refreshments & Exhibits
Session 4
Moderator – TBD
1445 - 1500 Pupils and The Swinging Flashlight Test
Dr. Lawrence Weisbrod
1500 – 1515 Acute Painless Visual Loss
Dr. Ted Christakis
1515 - 1530 Cosmetics and the Eye
Speaker TBD
1530 – 1545 The Red Eye – Identifying Vision Threatening Causes
Dr. Lawrence Weisbrod
1545 – 1600 Question & Answer Period (Panel)
1600
Closing Remarks – Dr. Lawrence Weisbrod